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Dysregulation of neuronal zinc homeostasis plays a major role in many processes related
to brain aging and neurodegenerative diseases, including Alzheimer’s disease (AD). Yet,
despite the critical role of zinc in neuronal function, the cellular mechanisms underpinning
its homeostatic control are far from clear. We reported that the cellular prion protein (PrPC)
is involved in the uptake of zinc into neurons. This PrPC-mediated zinc influx required the
metal-binding octapeptide repeats in PrPC and the presence of the zinc permeable AMPA
channel with which PrPC directly interacted. Together with the observation that PrPC is
evolutionarily related to the ZIP family of zinc transporters, these studies indicate that
PrPC plays a key role in neuronal zinc homeostasis. Therefore, PrPC could contribute to
cognitive health and protect against age-related zinc dyshomeostasis but PrPC has also
been identified as a receptor for amyloid-β oligomers which accumulate in the brains of
those with AD. We propose that the different roles that PrPC has are due to its interaction
with different ligands and/or co-receptors in lipid raft-based signaling/transport complexes.
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ZINC HOMEOSTASIS AND ALZHEIMER’S DISEASE
Zinc is a trace element that is essential for life and whose impor-
tance to the function of the central nervous system is increasingly
being appreciated. Zinc serves as a cofactor for >300 enzymes
that regulate a variety of cellular processes and signaling path-
ways, and is also a key structural component of numerous other
proteins (Frederickson et al., 2005; Sensi et al., 2009). In the brain,
which has one of the highest zinc contents with respect to other
organs, zinc-containing axons are particularly abundant in the
hippocampus and cortex (Toth, 2011). Zinc is predominantly,
but not exclusively, localized within synaptic vesicles at gluta-
matergic nerve terminals [sometimes referred to as gluzinergic
neurons (Mocchegiani et al., 2005)]. During neuronal activ-
ity, zinc is released along with glutamate into the synaptic cleft
where it affects the activity of various receptors. In addition,
zinc is itself a signaling molecule, and within the neuron it reg-
ulates the activity of multiple enzymes and plays a critical role
in the formation and stabilization of the postsynaptic density
(Beyersmann and Haase, 2001; Grabrucker et al., 2011; Wilson
et al., 2012). Both intracellular and extracellular zinc concentra-
tions must be tightly maintained within narrow optimal ranges
for the correct functioning of the nervous system. An excess
influx of zinc can damage postsynaptic neurons (Plum et al.,
2010) and zinc deficiency affects neurogenesis and increases neu-
ronal apoptosis, which can lead to learning and memory deficits
(Szewczyk, 2013). Under normal circumstances, zinc homeostasis
is maintained by the coordinated actions of a range of different
proteins involved in its uptake, efflux, and intracellular storage
and trafficking. Zinc enters neurons through members of the
ZIP (Zrt/Irt-like Protein; SLC39) family of zinc transporters, as
well as through activated voltage-gated Ca2+ channels, α-amino-
3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA) receptors,
and N-methyl-D-aspartate (NMDA) receptors (Cousins et al.,
2006; Sensi et al., 2009). Zinc exporters, members of the zinc
transporter (ZnT; SLC30) family transport zinc from the cytosol
to the lumen of intracellular organelles or out of the cell (Sensi
et al., 2009).
Alzheimer’s disease (AD) is themost prevalent form of demen-
tia, affecting millions of individuals world-wide. With currently
no cure, the economic and social costs associated with the dis-
ease are set to increase dramatically with our aging population.
AD is characterized by the deposition in the brain of extracellu-
lar plaques of amyloid-β (Aβ) peptide and intracellular inclusions
of tau protein. Aβ is proteolytically cleaved from the larger amy-
loid precursor protein (APP), and both Aβ and APP have binding
sites for zinc (Watt et al., 2010; Wong et al., 2014). Zinc, par-
ticularly that released from glutamatergic nerve terminals, has
a crucial role to play in the aggregation of Aβ into neuro-
toxic oligomers and fibrils (Bush et al., 1994; Esler et al., 1996;
Deshpande et al., 2009), and is also co-localized with Aβ in
amyloid plaques (Dong et al., 2003). The activity of the zinc
transporter ZnT-3 is required for the transport of zinc into the
glutamate-containing presynaptic vesicles. Key evidence for a link
between zinc and amyloid pathology in AD comes from the
crossing of ZnT-3 knockout mice with Tg2576 mice, a com-
monly used transgenic mouse model of AD. The crossed mice
had minimal synaptic zinc and as a consequence both brain
plaque load and amyloid angiopathy were significantly reduced
(Lee et al., 2002; Friedlich et al., 2004). Furthermore, in a sep-
arate study of aged ZnT-3 knockout mice, there were marked
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differences in learning and memory observed compared to wild
type mice, supporting a requirement for zinc in memory func-
tion and the maintenance of synaptic health upon aging (Adlard
et al., 2010).
PrPC AND NEURONAL ZINC UPTAKE
Recently we reported that PrPC facilitates the uptake of zinc
into neuronal cells (Watt et al., 2012). PrPC is infamous because
of its conformational conversion into PrPSc being responsible
for the fatal transmissible spongiform encephalopathies, such as
Creutzfeldt-Jakob disease. PrPC is a glycosyl-phosphatidylinositol
(GPI)-anchored protein located on the surface of neurons, at both
pre- and post-synaptic sites. It is found throughout the central
nervous system and is particularly abundant in the hippocam-
pus and frontal cortex (Sales et al., 1998). Using two zinc specific
fluorescent dyes (Newport green and Zinpyr-1) we showed that
PrPC enhanced the uptake of zinc into human SH-SY5Y neu-
roblastoma cells and rat primary hippocampal neurons (Watt
et al., 2012). This PrPC-mediated zinc influx required the metal-
binding octapeptide repeat region in PrPC but not its endocytosis.
We then used selective channel antagonists to identify that AMPA
receptors were involved in the PrPC-mediated zinc uptake, and
that PrPC interacted with both GluA1 and GluA2 AMPA recep-
tor subunits as shown by co-immunoprecipitation. Intracellular
protein tyrosine phosphatase activity, which is potently inhibited
by zinc (Brautigan et al., 1981; Wilson et al., 2012), was increased
in the brains of PrPC null mice, providing evidence of a physio-
logical consequence of altered zinc uptake in the absence of PrPC.
These observations provided the first mechanistic explanation for
the reduced zinc in the hippocampus and other brain regions of
PrPC null mice (Pushie et al., 2011) and indicate that PrPC is a key
player in neuronal zinc uptake.
Interestingly, during the course of our work showing that
PrPC mediates neuronal zinc uptake, the protein was reported
to be evolutionarily related to a subset of the ZIP family of zinc
transporters (Schmitt-Ulms et al., 2009). Bioinformatic analysis
revealed that the N-terminal extracellular domain of a distinct
sub-branch of the LIV-1 subfamily of ZIPs that includes ZIPs
5, 6, and 10 had sequence similarity to the C-terminal globu-
lar domain of PrPC. These three ZIPs are also equipped with
histidine-rich sequences N-terminal to their “prion-like” domain,
capable of divalent metal binding, which is reminiscent of the
octapeptide repeat domain of PrPC (Figure 1A). Interestingly, the
orientation and distance of the “prion-like” domain to the respec-
tive membrane attachment sites in both PrPC and the ZIPs are
similar (Figure 1A), and the primary sequence of the first trans-
membrane domain in the ZIPs and the GPI anchor attachment
sequence of PrPC are also comparable, providing further evidence
that PrPC is evolutionarily related to members of the ZIP family
(Schmitt-Ulms et al., 2009).
As PrPC is a GPI-anchored protein residing in the outer leaflet
of the plasma membrane, in order to correlate a function for
PrPC in the transport of zinc across the lipid bilayer, we pro-
posed that PrPC requires the assistance of the channel properties
of another protein(s), such as AMPA receptors, in order to achieve
zinc transport (Figure 1B) (Watt et al., 2012). The octapeptide
repeats in the GPI-anchored PrPC act as a zinc sensor/scavenger
in the extracellular environment which then presents the metal
to the transmembrane channel for uptake of the zinc into the
cell (Watt et al., 2013). Interestingly, not all ZIP family mem-
bers have an extracellular N-terminal extension that may function
in zinc sensing: for example ZIPs 1, 2, 3, 9, and 11 have mini-
mal N-terminal extensions on the first transmembrane domain.
This raises the intriguing possibility that the two properties (zinc
FIGURE 1 | Schematic comparison of ZIP transporters and the PrPC-AMPA
receptor zinc transporter. (A)Model of the LIV-1 subfamily of ZIPs with a
prion-like ectodomain which is coupled to the C-terminal transmembrane
domain. PrPC is structurally similar to the ectodomain of the ZIP transporter.
(B) PrPC acts as a sensor for zinc in the extracellular space and coordinates the
low affinity binding of zinc to the octapeptide repeats. The N-terminal polybasic
region of PrPC interacts with the AMPA receptor subunits; this interaction
facilitates the transport of zinc through the AMPA receptor which forms a
channel across the membrane for the uptake of zinc in a manner similar to the
C-terminal region of the ZIP transporter. Modified from Watt et al. (2013).
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sensing and zinc channel) present together in certain ZIPs (e.g.,
ZIPs 6 and 10) reside in separate proteins in those ZIPs with min-
imal N-terminal extensions. It will be interesting to see if PrPC
acts as the zinc sensor in combination with certain ZIPs, similar
to the situation we have proposed for PrPC and the AMPA recep-
tor (Figure 1B) (Watt et al., 2012, 2013). Such PrPC-based zinc
sensing modules may be restricted to higher eukaryotes in which
PrPC with the octapeptide metal binding repeats is present.
In addition to its role in zinc metabolism, PrPC also plays a
role in the homeostasis of other metals such as iron and cop-
per (Kozlowski et al., 2010; Singh et al., 2014). PrPC expression
alters regional zinc, copper and iron content in the mouse brain
(Pushie et al., 2011) and there appears to be crosstalk between
the different metals, with zinc modulating copper coordination
to the octapeptide repeats (Stellato et al., 2011). In addition, PrPC
modulates NMDA receptor activity in a copper-dependent man-
ner (Stys et al., 2012), suggesting that multiple receptors/channels
may be regulated by PrPC in a ligand/metal-dependent manner.
A CELL-SURFACE, LIPID RAFT-BASED COMPLEX INVOLVED
IN THE REGULATION OF ZINC UPTAKE
The GPI-anchored PrPC is localized in cholesterol-rich,
detergent-resistant lipid rafts at the cell surface (Taylor et al.,
2005) and it has been proposed that PrPC functions as a key
scaffolding protein for the dynamic assembly of cell surface
signaling modules (Linden et al., 2008). PrPC, along with the
microdomain-forming flotillin or caveolin proteins, may lead
to the local assembly of membrane protein complexes at sites
involved in cellular communication, such as cell-cell contacts,
focal adhesions, the T-cell cap and synapses (Solis et al., 2010).
Lipid rafts are essential for synapse development, stabilization
and maintenance and caveolin-1 organizes and targets synaptic
components to rafts (Hering et al., 2003; Willmann et al., 2006;
Guirland and Zheng, 2007). Interestingly, when ZIP1 and ZIP3
were stably expressed in HEK293 cells, the punctate cell surface
staining observed led the authors to suggest that they were
localized to lipid rafts (although no experimental evidence for
this was provided) (Wang et al., 2004). Furthermore, treatment of
the HEK293 cells with methyl-β-cyclodextrin, which sequesters
cholesterol and disrupts cholesterol-rich lipid rafts, resulted in
a more diffuse surface staining (Wang et al., 2004), reminiscent
of what is observed for PrPC and other GPI-anchored proteins
(Parkin et al., 2003; Taylor et al., 2005). We also have disrupted
rafts in neuronal cells using methyl-β-cyclodextrin and observed
a reduction in zinc uptake, an effect exacerbated when the
cells also expressed PrPC (Watt and Hooper, unpublished). In
contrast, it has been reported that ZIP10 only partially colocalizes
with PrPC in N2a cells and is not detected in detergent-resistant
rafts (Ehsani et al., 2012). These data raise the intriguing pos-
sibility that a cell-surface, lipid raft-based complex, possibly
stabilized by PrPC, regulates the cell surface expression of certain
zinc transporters and thus zinc uptake.
PrPC IS A CELL SURFACE RECEPTOR FOR Aβ OLIGOMERS
In 2009, PrPC was identified as a high-affinity receptor for Aβ
oligomers, the primary neurotoxic species in AD (Lauren et al.,
2009). The presence of PrPC in hippocampal slices was shown
to be responsible for the Aβ oligomer-mediated inhibition of
long-term potentiation (LTP) (Lauren et al., 2009). PrPC was also
required for the manifestation of memory impairments in an AD
mouse model (Gimbel et al., 2010), which were reversed by intra-
cerebral infusion of an anti-PrPC monoclonal antibody (Chung
et al., 2010). Immuno-targeting of PrPC was shown to block com-
pletely the LTP impairments caused by Aβ oligomers derived from
human AD brain extracts (Barry et al., 2011; Freir et al., 2011).
Aβ oligomers bound to PrPC activate the non-receptor tyrosine
kinase Fyn (Um et al., 2012; Rushworth et al., 2013) and results
in pathological changes in tau (Larson et al., 2012). Although
there is general consensus that PrPC can bind oligomeric forms of
Aβ, some studies dispute a role for PrPC in mediating Aβ toxicity
(Calella et al., 2010; Kessels et al., 2010).
It has been hypothesized that a putative transmembrane co-
receptor is required to connect the binding of Aβ to the GPI-
anchored PrPC on the outer surface of the plasma membrane
with downstream effects inside the cell (Cisse and Mucke, 2009;
Lauren et al., 2009). The transmembrane low-density lipoprotein-
receptor related protein-1 (LRP1) is highly expressed in neuronal
cells (Nykjaer and Willnow, 2002), facilitates the endocytosis of
PrPC (Taylor and Hooper, 2007) and has been implicated in the
neuronal uptake of Aβ (Fuentealba et al., 2010; Kanekiyo et al.,
2011). We hypothesized, therefore, that LRP1 may play a role in
the PrPC-mediated action of Aβ oligomers (Figure 2). We showed
that LRP1 is required for the binding of Aβ oligomers to cells,
as well as for their subsequent internalization and cytotoxicity
(Rushworth et al., 2013). In parallel with our work on LRP1,
Strittmatter and colleagues identified the metabotropic glutamate
receptor, mGluR5, as a co-receptor with PrPC for Aβ oligomers
and was required to activate Fyn (Um et al., 2013). Furthermore,
antagonists of mGluR5 reversed the deficits in learning, memory
and synapse density in AD transgenic mice (Um et al., 2013). In
addition, the Aβ-PrPC-mGluR5 interplay is involved inmediating
both long-term depression facilitation and LTP inhibition (Hu
et al., 2014). Thus, both LRP1 and mGluR5 appear to be trans-
membrane co-receptors in the Aβ-PrPC interaction, which are
required for the PrPC-mediated action of Aβ oligomers. Whether
both LRP1 and mGluR5 reside in the same complex with PrPC or
in separate signaling complexes is currently unclear.
A CELL-SURFACE, LIPID RAFT-BASED SIGNALING COMPLEX
INVOLVED IN Aβ OLIGOMER ACTION
Cell surface cholesterol-rich, detergent-resistant lipid rafts are
intimately involved in the production, aggregation and toxic-
ity of Aβ (Rushworth and Hooper, 2010; Di Paolo and Kim,
2011). For example, these membrane microdomains have been
linked with Aβ toxicity via Fyn, and rafts are involved in the
neuronal internalization of Aβ (Williamson et al., 2008; Lai
and McLaurin, 2010). We investigated whether the integrity of
lipid rafts is required for the binding of Aβ oligomers and the
subsequent activation of Fyn. Treatment of cells with methyl-
β-cyclodextrin caused the re-localization of PrPC and Fyn from
detergent-resistant rafts to detergent-soluble, non-raft regions of
the membrane as analyzed by sucrose density gradient centrifu-
gation in the presence of Triton X-100. Surprisingly, disruption
of the rafts with methyl-β-cyclodextrin significantly reduced (by
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FIGURE 2 | Schematic of PrPC-based cell-surface, raft-based complexes
involved in zinc uptake and Aβ binding. PrPC acts as a hub for cell surface,
lipid raft-based signaling/transport complexes. PrPC associates with various
transmembrane proteins (such as AMPA receptors, LRP1, mGluR5, etc.) in
these multi-protein complexes in a ligand-dependent manner (here shown for
the ligands zinc and Aβ oligomers within separate raft-based complexes).
80.6%) the cell surface binding of the Aβ oligomers, even though
the cell surface expression of PrPC was unaffected, and prevented
the Aβ oligomers from activating Fyn (Rushworth et al., 2013).
Thus, raft localization of PrPC is required for the binding of Aβ
oligomers, and the integrity of rafts and/or other raft-localized
proteins are required for the Aβ-mediated activation of Fyn.
These observations suggest that there is a cell-surface, raft-based
signaling complex that is key to the binding of Aβ oligomers and
the subsequent generation of cellular responses.
Aβ oligomers caused mGluR5 receptors to manifest reduced
lateral diffusion as they became aberrantly clustered (Renner
et al., 2010). Antibodies against PrPC and the NR1 subunit of
NMDA receptors had a similar inhibitory effect on Aβ oligomer
binding as the antibody against mGluR5, but there was not
an additive effect of the individual antibodies, suggesting that
mGluR5, PrPC, andNR1may be in proximity to each other as well
as the Aβ oligomer binding site (Renner et al., 2010). Interestingly,
addition of Aβ oligomers to neurons caused a large increase of
mGluR5 in the Triton-resistant fraction (Renner et al., 2010),
although no link to its possible redistribution into detergent-
resistant lipid rafts was made. In another study, disruption of lipid
rafts by cholesterol depletion reduced the interaction of Aβ with
α-7-nicotinic acetylcholine receptors (Khan et al., 2010). These
observations are consistent with multiple (co)receptor proteins
for Aβ oligomers residing in cell-surface, raft-based complex(es).
PrPC AND RAFTS ARE DYSREGULATED IN AGING
Zinc homeostasis plays a major role in many processes related
to brain aging. For example, mouse models of accelerated aging,
such as senescence-accelerated mouse prone 10 (SAMP10) mice
display a low total zinc concentration in synaptic vesicles that is
associated with brain atrophy and defects in learning and mem-
ory (Saito et al., 2000), and dietary zinc deficiency influences
hippocampal learning and memory in an age-dependent man-
ner (Mocchegiani et al., 2005; Szewczyk, 2013). ZIP6 expression
has been reported to be decreased in an age-dependent manner
(Wong et al., 2013), although nothing has been reported about
the expression, subcellular localization or function of any other
ZIP in the aged brain. Caveolin-1 has been identified as a novel
control point for healthy neuronal aging, with the localization
of caveolin-1, PSD95, and AMPA receptors in lipid rafts being
decreased in aged (>18 months) mice compared with young (3–6
month) mice (Head et al., 2010). Furthermore, in an aging series
(age 20–88 years) of human brains we reported that PrPC was
reduced in the hippocampus with increasing age (Whitehouse
et al., 2010). Preliminary data indicate that there is a significant
reduction of both ZIP1 and ZIP3 in the hippocampus of old (79–
88 years) compared with young (20–26 years) individuals (Watt
and Hooper, unpublished). These observations suggest that alter-
ations to the structure and function of the cell-surface, raft-based
zinc transporter complex may occur in aging and contribute to
the age-related dysregulated zinc homeostasis.
Aging is the greatest risk factor for AD and recently the REST
protein was reported to have a central role in protecting aging
neurons from degeneration (Lu et al., 2014). There is a close rela-
tionship between lipid rafts, cholesterol, and the age-associated
decline and dysregulation of cellular signaling pathways (Ohno-
Iwashita et al., 2010). A key component of a subset of rafts,
caveolin-1, was identified as a novel control point for both Aβ-
based neurodegeneration and healthy neuronal aging (Head et al.,
2010), and caveolin-1 expression is altered in AD (Gaudreault
et al., 2004). In addition, the level of PrPC is altered in both
the AD and aging brain (Whitehouse et al., 2010, 2013; Larson
et al., 2012). Thus, dysregulation of the structure and function
of cell-surface, raft-based signaling complexes may occur in, and
contribute to, both AD and aging.
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CONCLUSION
PrPC appears to be involved in multiple physiological and patho-
logical processes, including as highlighted here, neuronal zinc
uptake and Aβ oligomer binding and toxicity. We propose that
PrPC acts as a hub for cell surface, lipid raft-based signal-
ing/transport complexes, and that the different roles that the
protein has are due to the selective interaction of PrPC with dif-
ferent ligands (such as zinc or Aβ oligomers) and/or co-receptors
(such as AMPA receptors, LRP1, mGluR5) in these multi-protein
complexes (Figure 2). It is likely that these complexes are rel-
atively transient in nature, being stabilized upon binding of a
particular ligand for a limited time period before dissociation or
endocytosis terminates the signaling or transport process. The use
of more sophisticated techniques, such as super resolution light
microscopy, should enable the molecular details of these different
lipid raft-based signaling/transport complexes to be determined
and provide a clearer picture of the role of PrPC and lipid rafts in
neuronal zinc transport and Aβ action in AD. It will also be inter-
esting to determine how the interplay between PrPC, zinc, and Aβ
may underlie aging and age-related diseases.
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